May 11, 2023, Inside Medical Liability Online
Postpartum Malpractice Claims: Can We Understand Preventable Harms and Socioeconomic Factors?
Rates for maternal morbidity and mortality are higher in the U.S. than in any other developed country—and many of the harms suffered by patients are preventable. In a multifactorial study, David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group; Jacqueline Ross, PhD, RN, CPAN, Coding Director, Department of Patient Safety and Risk Management, The Doctors Company, and Shelise Valentine, RNC, MSN, Director of Clinical Education, Healthcare Risk Advisors, part of TDC Group, investigated postpartum claims to develop clinical recommendations to decrease the risks of postpartum morbidity and mortality.
Search
Inflation Added $4 Billion to Medical Malpractice Losses, The Doctors Company Study Finds
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, today released new research indicating that inflation—both economic and social—has added an estimated $4 billion in insured losses and expenses to the medical malpractice insurance market over the past decade.
The Doctors Company Announces New Tribute Plan Milestone: $175 Million Distributed to Members
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has now distributed more than $175 million in Tribute® Plan awards to almost 14,000 members.
Nov 30, 2022
Healthcare Inequities Post-Roe: Clinician Perspectives
Many states with abortion bans are also states with higher proportions of people of color, increasing the uneven impacts of the Dobbs decision, which overturned Roe v. Wade.
May 01, 2024, AM Best
AM Best’s Briefing - Medical Professional Liability Sector: The State of the U.S. Market
Robert E. White, President of The Doctors Company and TDC Group, joins Sharon Pereira Marks, Director, P&C Ratings, AM Best; Victoria Riggs, MBA, Associate Director, AM Best; Eric Anderson, Interim President and CEO, the Medical Professional Liability Association; and Megan McIntyre, Head of TransRe’s Medical Malpractice team, in reviewing the state of the U.S. medical professional liability insurance sector.
March 14, 2022, KevinMD
Tackling Trial Delays, Social Inflation, and Skeptical Jurors in a Pandemic World
Marco Spadacenta, Senior Vice President of Claims for The Doctors Company, discusses the changing face of trials and jurors and suggests what can be done in light of these changes to successfully defend physicians in medical malpractice cases.
Leadership
We lead the medical malpractice industry because of the leaders in our boardroom. Read biographies of The Doctors Company Board of Governors members.
AM Best Revises Outlooks to Positive for The Doctors Company and Subsidiaries
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group).
Exclusively Sponsored by the American Association of Neurological Surgeons
The American Association of Neurological Surgeons exclusively sponsors The Doctors Company. AANS members receive unique benefits, including exclusive program discounts and credits.
The High Costs of Defensive Medicine
“Defensive medicine” is an increasingly common practice that should concern every American woman—the growing tendency of doctors to order needless tests to establish a medical record for their defense in case they are sued. Defensive medicine exacts huge costs, in both fiscal and human terms.
